Yale School of Medicine recently announced the formation of the Stephen and Denise Adams Center for Parkinson’s Disease Research, whose goal is to change the ways that Parkinson’s is diagnosed and treated. The neurological disorder currently affects an estimated one million people in the United States.
The director of the new center will be Clemens Scherzer, MD, who comes to Yale in January 2024 from Harvard Medical School. Scherzer says the resources available at Yale for Parkinson’s research are formidable, and he looks forward to bringing together scientists and engineers across disciplines from neurology, neuroscience, cell biology, genetics, bioinformatics, and computer science to advance research on Parkinson’s.
The center and the recruitment of Dr. Scherzer were made possible by the support of Stephen Adams ’59, and his wife, Denise. Their gift will help to reveal the biological underpinnings of Parkinson’s disease, advance targeted therapies for the disease, and move forward the delivery of cutting-edge research and care in New Haven and beyond.